ChemicalBook--->CAS DataBase List--->1427376-05-3

1427376-05-3

1427376-05-3 Structure

1427376-05-3 Structure
IdentificationBack Directory
[Name]

Solifenacin Related Compound 19
[CAS]

1427376-05-3
[Synonyms]

Solifenacin Related Compound 19
(1S,3R,4S)-Quinuclidin-3-yl Benzylcarbamate
Carbamic acid, N-(phenylmethyl)-, 1-azabicyclo[2.2.2]oct-3-yl ester
[Molecular Formula]

C15H20N2O2
[MOL File]

1427376-05-3.mol
[Molecular Weight]

260.33
Chemical PropertiesBack Directory
[Boiling point ]

415.8±34.0 °C(Predicted)
[density ]

1.18±0.1 g/cm3(Predicted)
[pka]

12.53±0.46(Predicted)
1427376-05-3 suppliers list
Company Name: Nanjing XiZe Biotechnology CO., Ltd.  
Tel: 025-66023220 0086-15250997978
Website: http://www.njxizebio.com
Company Name: HX Pharmaceutical technology co., LTD  
Tel: 15671363360
Website: www.szhx-pharm.com
Company Name: Shenzhen Excellent Biomedical Technology Co., Ltd.  
Tel: 0755-26050679 18318671572
Website: www.ex-biotech.com/
Company Name: SynZeal Research Pvt Ltd  
Tel: +1 226-802-2078
Website: www.synzeal.com
Company Name: Pharmaffiliates Analytics and Synthetics P. Ltd  
Tel: +91-172-5066494
Website: www.pharmaffiliates.com
Tags:1427376-05-3 Related Product Information
180272-45-1 242478-38-2 862207-70-3 25333-42-0 862207-71-4 1243274-81-8 180272-28-0 52250-50-7 1225338-27-1 180468-42-2 34583-34-1 1426174-05-1 1956436-64-8 22990-19-8 118864-75-8 1193-65-3 3731-38-2 861998-77-8

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.